Every Member is encouraged to start a thread for discussion on a stock of his/her choice. There are no restrictions. But there are some caveats, as any Forum that prides itself on the Content/Quality of discussions, would.
Please make sure not to duplicate threads by searching first for the company/business to spot an already existing thread. A discussion must be started with an influencing piece. As the thread initiator, it is expected of you to have done some homework of your own - thinking through the Positives, Negatives, Risks on the stock idea, giving some details on why you think it may be a good idea to discuss this opportunity.
This simple measure will invite more participation from Members, and ensure that you achieve your objective - discussion/guidance/feedback/critique on your stock idea. A bland 2-3 lines - “what do you think of ABCD at current levels”, or “ABCD Target 123 in 6 months- year” are not the kind of discussion we want to encourage at ValuePickr.
ValuePickr prides itself on being a self-moderated Forum, almost. Hope we can continue this excellent culture.
The starting piece does not have to a big thesis - even 3-4 paras on the main Investment thesis covering positives, negatives, risks, and some interesting aspects is enough. If you are already invested in the stock, proper disclosure is encouraged - helps building your own credibility among members.A good example of a starting thread is as below.
Posted byHitesh Patelat October 02. 2012
JB Chemicals seems to be a good value pick.
current market cap of around 640 crores.
Company has cash and investments of around 550 crores and debt of around 70 crores.
Effectively company has cash and equivalents of 480 crores. (this i assume after calculating the special dividend paid to shareholders of around 40 rs per share.)
So one gets the company at effective price of 160 crores. This for a company which has presence in India, and a lot of other export markets.
June qtr revenues has been around 190 crores. Some rough extrapolation gives yearly sales figure of around 800 crores. Company is available at market cap to sales of 0.2 which seems very attractive.
Company last year sold off its OTC business in Russia and CIS countries for a net income of 760 crores. It paid special interim dividend of 338 crores and tax thereon of 55 crores.
Jb chemcials seems to be in deep undervaluation territory with company available at an enterprise value of 160 crores and market cap to sales ratio of 0.2.
Going through the fy 12 AR, management seems upbeat about the prospects of remaining parts of the business which mainly includes Indian operations and Rest of World exports.
Looks like a low risk high return kind of scenario for the patient investor bcos once the company gets its act together post selling the Russian-CIS OTC business, there could be a strong appetite for the stock even as a growth stock.
Interesting to note here that Ashish Dhawan (formerly of Cryscapital) has been consistently increasing his stake in this one over the past few quarters and currently holds around 10% stake.
disc: Initial entry into the stock at around 75 per share.